{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:44Z","timestamp":1792790564356,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008947","name":"Stiftung Synapsis - Alzheimer Forschung Schweiz AFS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"M\u00e4xi Foundation, Zurich, Switzerland","id":[{"id":"https:\/\/ror.org\/003egza52","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008494","name":"Vontobel-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This work aimed to investigate potential pathways linking age and imaging measures to early age- and pathology-related changes in cognition. We used [18F]-Flutemetamol (amyloid) and [18F]-Flortaucipir (tau) positron emission tomography (PET), structural MRI, and neuropsychological assessment from 232 elderly individuals aged 50\u201389 years (46.1% women, 23% APOE-\u03b54 carrier, 23.3% MCI). Tau-PET was available for a subsample of 93 individuals. Structural equation models were used to evaluate cross-sectional pathways between age, amyloid and tau burden, grey matter thickness and volumes, white matter hyperintensity volume, lateral ventricle volume, and cognition. Our results show that age is associated with worse outcomes in most of the measures examined and had similar negative effects on episodic memory and executive functions. While increased lateral ventricle volume was consistently associated with executive function dysfunction, participants with mild cognitive impairment drove associations between structural measures and episodic memory. Both age and amyloid-PET could be associated with medial temporal lobe tau, depending on whether we used a continuous or a dichotomous amyloid variable. Tau burden in entorhinal cortex was related to worse episodic memory in individuals with increased amyloid burden (Centiloid &gt;12) independently of medial temporal lobe atrophy. Testing models for sex differences revealed that amyloid burden was more strongly associated with regional atrophy in women compared with men. These associations were likely mediated by higher tau burden in women. These results indicate that influences of pathological pathways on cognition and sex-specific vulnerabilities are dissociable already in early stages of neuropathology and cognitive impairment.<\/jats:p>","DOI":"10.1038\/s41398-023-02572-6","type":"journal-article","created":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T23:08:09Z","timestamp":1691968089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Age-, sex-, and pathology-related variability in brain structure and cognition"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-537X","authenticated-orcid":false,"given":"Dario","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Saake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Rauen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger M.","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Gietl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3031","authenticated-orcid":false,"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"2572_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1515\/REVNEURO.2010.21.3.187","volume":"21","author":"AM Fjell","year":"2010","unstructured":"Fjell AM, Walhovd KB. Structural Brain Changes in Aging: Courses, Causes and Cognitive Consequences. Rev Neurosci. 2010;21:187\u2013222.","journal-title":"Rev Neurosci"},{"key":"2572_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134:171\u201386.","journal-title":"Acta Neuropathol"},{"key":"2572_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/cercor\/bhu238","volume":"26","author":"T Hedden","year":"2016","unstructured":"Hedden T, Schultz AP, Rieckmann A, Mormino EC, Johnson KA, Sperling RA, et al. Multiple Brain Markers are Linked to Age-Related Variation in Cognition. Cereb Cortex. 2016;26:1388\u20131400.","journal-title":"Cereb Cortex"},{"key":"2572_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ana.25600","volume":"86","author":"P Vemuri","year":"2019","unstructured":"Vemuri P, Lesnick TG, Knopman DS, Przybelski SA, Reid RI, Mielke MM, et al. Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging. Ann Neurol. 2019;86:866\u201377.","journal-title":"Ann Neurol"},{"key":"2572_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","volume":"77","author":"W Jagust","year":"2013","unstructured":"Jagust W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron. 2013;77:219\u201334.","journal-title":"Neuron"},{"key":"2572_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimer\u2019s Dement. 2019;15:888\u201398.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2572_CR7","doi-asserted-by":"crossref","unstructured":"d\u2019Arbeloff T, Elliott ML, Knodt AR, Melzer TR, Keenan R, Ireland D et al. White matter hyperintensities are common in midlife and already associated with cognitive decline. Brain Commun. 2019; 1.","DOI":"10.1093\/braincomms\/fcz041"},{"key":"2572_CR8","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","volume":"38","author":"SL Leal","year":"2018","unstructured":"Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold Amyloid Predicts Tau Deposition in Aging. J Neurosci. 2018;38:4482\u20139.","journal-title":"J Neurosci"},{"key":"2572_CR9","doi-asserted-by":"publisher","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","volume":"90","author":"SM Landau","year":"2018","unstructured":"Landau SM, Horng A, Jagust WJ. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90:e1452\u2013e1460.","journal-title":"Neurology"},{"key":"2572_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ana.26460","volume":"92","author":"W-YW Yau","year":"2022","unstructured":"Yau W-YW, Shirzadi Z, Yang H-S, Ikoba AP, Rabin JS, Properzi MJ, et al. Tau Mediates Synergistic Influence of Vascular Risk and A\u03b2 on Cognitive Decline. Ann Neurol. 2022;92:745\u201355.","journal-title":"Ann Neurol"},{"key":"2572_CR11","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, et al. Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation. Neurology. 2021;96:e619\u2013e631.","journal-title":"Neurology"},{"key":"2572_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1212\/WNL.0000000000007747","volume":"93","author":"GN Bischof","year":"2019","unstructured":"Bischof GN, Jacobs HIL. Subthreshold amyloid and its biological and clinical meaning: Long way ahead. Neurology. 2019;93:72\u201379.","journal-title":"Neurology"},{"key":"2572_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","volume":"117","author":"AM Fjell","year":"2014","unstructured":"Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB. What is normal in normal aging? Effects of aging, amyloid and Alzheimer\u2019s disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014;117:20\u201340.","journal-title":"Prog Neurobiol"},{"key":"2572_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell"},{"key":"2572_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol aging. 1997;18:351\u20137.","journal-title":"Neurobiol aging"},{"key":"2572_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease. NeuroImage. 2017;157:448\u201363.","journal-title":"NeuroImage"},{"key":"2572_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart Samuel N, Schonhaut Daniel R, O\u2019Neil James P, Janabi M, Ossenkoppele R, et al. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"2572_CR18","doi-asserted-by":"publisher","first-page":"100039","DOI":"10.1016\/j.brain.2021.100039","volume":"2","author":"A Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer A, Chaggar P, Thompson TB, Goriely A, Kuhl E. Predicting brain atrophy from tau pathology: a summary of clinical findings and their translation into personalized models. Brain Multiphys. 2021;2:100039.","journal-title":"Brain Multiphys"},{"key":"2572_CR19","doi-asserted-by":"publisher","first-page":"eaau5732","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12:eaau5732.","journal-title":"Sci Transl Med"},{"key":"2572_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20:222\u201334.","journal-title":"Lancet Neurol"},{"key":"2572_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157\u201365.","journal-title":"Nat Rev Neurol"},{"key":"2572_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamaneurol.2018.3122","volume":"76","author":"S Debette","year":"2019","unstructured":"Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis. JAMA Neurol. 2019;76:81\u201394.","journal-title":"JAMA Neurol"},{"key":"2572_CR23","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awv191","volume":"138","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Pijnenburg YAL, Perry DC, Cohn-Sheehy BI, Scheltens NME, Vogel JW, et al. The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features. Brain. 2015;138:2732\u201349.","journal-title":"Brain"},{"key":"2572_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuron.2004.09.006","volume":"44","author":"RL Buckner","year":"2004","unstructured":"Buckner RL. Memory and Executive Function in Aging and AD: Multiple Factors that Cause Decline and Reserve Factors that Compensate. Neuron. 2004;44:195\u2013208.","journal-title":"Neuron"},{"key":"2572_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1017\/S1355617710000706","volume":"16","author":"TA Salthouse","year":"2010","unstructured":"Salthouse TA. Selective review of cognitive aging. J Int Neuropsychol Soc. 2010;16:754\u201360.","journal-title":"J Int Neuropsychol Soc"},{"key":"2572_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-267","volume":"3","author":"TN Beran","year":"2010","unstructured":"Beran TN, Violato C. Structural equation modeling in medical research: a primer. BMC Res Notes. 2010;3:267.","journal-title":"BMC Res Notes"},{"key":"2572_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240\u20136.","journal-title":"J Intern Med"},{"key":"2572_CR28","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1523\/JNEUROSCI.5506-12.2013","volume":"33","author":"AM Fjell","year":"2013","unstructured":"Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB. Initiative AsDN. Brain changes in older adults at very low risk for Alzheimer\u2019s disease. J Neurosci. 2013;33:8237\u201342.","journal-title":"J Neurosci"},{"key":"2572_CR29","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/brain\/awn146","volume":"131","author":"SM Nestor","year":"2008","unstructured":"Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database. Brain. 2008;131:2443\u201354.","journal-title":"Brain"},{"key":"2572_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","volume":"62","author":"CR Jack Jr","year":"2004","unstructured":"Jack CR Jr, Shiung MM, Gunter JL, O\u2019Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62:591\u2013600.","journal-title":"Neurology"},{"key":"2572_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.nicl.2016.11.020","volume":"13","author":"C Egger","year":"2017","unstructured":"Egger C, Opfer R, Wang C, Kepp T, Sormani MP, Spies L, et al. MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation? Neuroimage Clin. 2017;13:264\u201370.","journal-title":"Neuroimage Clin"},{"key":"2572_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1\u201315. e11-14","journal-title":"Alzheimers Dement"},{"key":"2572_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-019-0478-z","volume":"11","author":"G Salvad\u00f3","year":"2019","unstructured":"Salvad\u00f3 G, Molinuevo JL, Brugulat-Serrat A, Falcon C, Grau-Rivera O, Su\u00e1rez-Calvet M, et al. Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers. Alzheimers Res Ther. 2019;11:27.","journal-title":"Alzheimers Res Ther"},{"key":"2572_CR34","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28:2381\u20137.","journal-title":"Nat Med"},{"key":"2572_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data Brief. 2017;15:648\u201357.","journal-title":"Data Brief"},{"key":"2572_CR36","doi-asserted-by":"publisher","first-page":"102708","DOI":"10.1016\/j.nicl.2021.102708","volume":"31","author":"R Smith","year":"2021","unstructured":"Smith R, Strandberg O, Leuzy A, Betthauser TJ, Johnson SC, Pereira JB, et al. Sex differences in off-target binding using tau positron emission tomography. Neuroimage Clin. 2021;31:102708.","journal-title":"Neuroimage Clin"},{"key":"2572_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ana.26417","volume":"92","author":"D Bachmann","year":"2022","unstructured":"Bachmann D, Roman ZJ, Buchmann A, Zuber I, Studer S, Saake A, et al. Lifestyle Affects Amyloid Burden and Cognition Differently in Men and Women. Ann Neurol. 2022;92:451\u201363.","journal-title":"Ann Neurol"},{"key":"2572_CR38","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1093\/brain\/awab114","volume":"144","author":"D Berron","year":"2021","unstructured":"Berron D, Vogel JW, Insel PS, Pereira JB, Xie L, Wisse LEM, et al. Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain. 2021;144:2771\u201383.","journal-title":"Brain"},{"key":"2572_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, et al. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging. J Neurosci. 2018;38:530\u201343.","journal-title":"J Neurosci"},{"key":"2572_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2967\/jnumed.122.263948","volume":"64","author":"S Flores","year":"2022","unstructured":"Flores S, Chen CD, Su Y, Dincer A, Keefe SJ, McKay NS, et al. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer disease. J Nucl Med. 2022;64:287\u201393.","journal-title":"J Nucl Med"},{"key":"2572_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hbm.25364","volume":"43","author":"S Frangou","year":"2022","unstructured":"Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, et al. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90\u2009years. Hum Brain Mapp. 2022;43:431\u201351.","journal-title":"Hum Brain Mapp"},{"key":"2572_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/cercor\/bhs379","volume":"24","author":"AM Fjell","year":"2014","unstructured":"Fjell AM, Westlye LT, Grydeland H, Amlien I, Espeseth T, Reinvang I, et al. Accelerating cortical thinning: unique to dementia or universal in aging? Cereb Cortex. 2014;24:919\u201334.","journal-title":"Cereb Cortex"},{"key":"2572_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2021.09.017","volume":"109","author":"LE Wisse","year":"2022","unstructured":"Wisse LE, Xie L, Das SR, de Flores R, Hansson O, Habes M, et al. Tau pathology mediates age effects on medial temporal lobe structure. Neurobiol Aging. 2022;109:135\u201344.","journal-title":"Neurobiol Aging"},{"key":"2572_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neurobiolaging.2013.08.007","volume":"35","author":"D Mungas","year":"2014","unstructured":"Mungas D, Tractenberg R, Schneider JA, Crane PK, Bennett DA. A 2-process model for neuropathology of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:301\u20138.","journal-title":"Neurobiol Aging"},{"key":"2572_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years. J Neuropathol Exp Neurol. 2011;70:960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2572_CR46","doi-asserted-by":"publisher","first-page":"eabc0655","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"JS Sanchez","year":"2021","unstructured":"Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci Transl Med. 2021;13:eabc0655.","journal-title":"Sci Transl Med"},{"key":"2572_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2018.04.007","volume":"68","author":"H Cho","year":"2018","unstructured":"Cho H, Lee HS, Choi JY, Lee JH, Ryu YH, Lee MS, et al. Predicted sequence of cortical tau and amyloid-\u03b2 deposition in Alzheimer disease spectrum. Neurobiol Aging. 2018;68:76\u201384.","journal-title":"Neurobiol Aging"},{"key":"2572_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia. Brain. 2018;141:271\u201387.","journal-title":"Brain"},{"key":"2572_CR49","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awac299","volume":"146","author":"PS Insel","year":"2022","unstructured":"Insel PS, Young CB, Aisen PS, Johnson KA, Sperling RA, Mormino EC, et al. Tau positron emission tomography in preclinical Alzheimer\u2019s disease. Brain. 2022;146:700\u201311.","journal-title":"Brain"},{"key":"2572_CR50","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.neuron.2022.03.034","volume":"110","author":"WJ Lee","year":"2022","unstructured":"Lee WJ, Brown JA, Kim HR, La Joie R, Cho H, Lyoo CH, et al. Regional A\u03b2-tau interactions promote onset and acceleration of Alzheimer\u2019s disease tau spreading. Neuron. 2022;110:1932\u20131943.e1935.","journal-title":"Neuron"},{"key":"2572_CR51","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","volume":"78","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, et al. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. JAMA Neurol. 2021;78:961\u201371.","journal-title":"JAMA Neurol"},{"key":"2572_CR52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1523\/JNEUROSCI.2111-20.2020","volume":"41","author":"X Chen","year":"2021","unstructured":"Chen X, Cassady KE, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults. J Neurosci. 2021;41:366\u201375.","journal-title":"J Neurosci"},{"key":"2572_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85:181\u201393.","journal-title":"Ann Neurol"},{"key":"2572_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755\u201366.","journal-title":"Acta Neuropathol"},{"key":"2572_CR55","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/brain\/awz403","volume":"143","author":"M Teylan","year":"2020","unstructured":"Teylan M, Mock C, Gauthreaux K, Chen YC, Chan KCG, Hassenstab J, et al. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. Brain. 2020;143:611\u201321.","journal-title":"Brain"},{"key":"2572_CR56","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jalz.2019.05.009","volume":"15","author":"SR Das","year":"2019","unstructured":"Das SR, Xie L, Wisse LEM, Vergnet N, Ittyerah R, Cui S, et al. In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals. Alzheimers Dement. 2019;15:1286\u201395.","journal-title":"Alzheimers Dement"},{"key":"2572_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","volume":"18","author":"JL Podcasy","year":"2016","unstructured":"Podcasy JL, Epperson CN. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci. 2016;18:437\u201346.","journal-title":"Dialogues Clin Neurosci"},{"key":"2572_CR58","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ana.25878","volume":"88","author":"RF Buckley","year":"2020","unstructured":"Buckley RF, Scott MR, Jacobs HIL, Schultz AP, Properzi MJ, Amariglio RE, et al. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline. Ann Neurol. 2020;88:921\u201332.","journal-title":"Ann Neurol"},{"key":"2572_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2021.03.007","volume":"103","author":"P Palta","year":"2021","unstructured":"Palta P, Rippon B, Tahmi M, Pardo M, Johnson A, Tomljanovic Z, et al. Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults. Neurobiol Aging. 2021;103:109\u201316.","journal-title":"Neurobiol Aging"},{"key":"2572_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.26382","volume":"92","author":"RF Buckley","year":"2022","unstructured":"Buckley RF, O\u2019Donnell A, McGrath ER, Jacobs HIL, Lois C, Satizabal CL, et al. Menopause status moderates sex differences in tau burden: a Framingham PET Study. Ann Neurol. 2022;92:11\u201322.","journal-title":"Ann Neurol"},{"key":"2572_CR61","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jamaneurol.2019.5154","volume":"77","author":"R Ossenkoppele","year":"2020","unstructured":"Ossenkoppele R, Lyoo CH, Jester-Broms J, Sudre CH, Cho H, Ryu YH, et al. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease. JAMA Neurol. 2020;77:632\u201342.","journal-title":"JAMA Neurol"},{"key":"2572_CR62","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.0000000000002570","volume":"86","author":"EE Sundermann","year":"2016","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, et al. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86:1368\u201376.","journal-title":"Neurology"},{"key":"2572_CR63","doi-asserted-by":"publisher","first-page":"e1881","DOI":"10.1212\/WNL.0000000000008467","volume":"93","author":"EE Sundermann","year":"2019","unstructured":"Sundermann EE, Maki P, Biegon A, Lipton RB, Mielke MM, Machulda M, et al. Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI. Neurology. 2019;93:e1881\u2013e1889.","journal-title":"Neurology"},{"key":"2572_CR64","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2013.10.074","volume":"35","author":"L Yu","year":"2014","unstructured":"Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014;35:819\u201326.","journal-title":"Neurobiol Aging"},{"key":"2572_CR65","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2018","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartr\u00e9s-Faz D, Belleville S, Cantilon M, Chetelat G, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer\u2019s Dementia. 2018;16:1305\u201311.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"2572_CR66","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","volume":"2","author":"J Therriault","year":"2022","unstructured":"Therriault J, Pascoal TA, Lussier FZ, Tissot C, Chamoun M, Bezgin G, et al. Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging. Nat Aging. 2022;2:526\u201335.","journal-title":"Nat Aging"},{"key":"2572_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00590-4","volume":"18","author":"CB Young","year":"2023","unstructured":"Young CB, Johns E, Kennedy G, Belloy ME, Insel PS, Greicius MD, et al. APOE effects on regional tau in preclinical Alzheimer\u2019s disease. Mol Neurodegeneration. 2023;18:1.","journal-title":"Mol Neurodegeneration"},{"key":"2572_CR68","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrn3338","volume":"13","author":"C Ranganath","year":"2012","unstructured":"Ranganath C, Ritchey M. Two cortical systems for memory-guided behaviour. Nat Rev Neurosci. 2012;13:713\u201326.","journal-title":"Nat Rev Neurosci"},{"key":"2572_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-018-0014-y","volume":"14","author":"A Ter Telgte","year":"2018","unstructured":"Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol. 2018;14:387\u201398.","journal-title":"Nat Rev Neurol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02572-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T08:06:47Z","timestamp":1700381207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2572"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02572-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CH and RMN are employees and shareholders of Neurimmune. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}